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The author has been treating extensive cases of
alopecia areata with 1-chloro-2, 4-dinitrobenzene
(DNCB) for 35 years with considerable success. This
presentation outlines the protocol that has been used.
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The use of 1 chloro-2,4-dinitrobenzene (DNCB) to treat
extensive alopecia areata was first reported to be successful
in 1976 based on two cases in whom half of the bare scalp
was treated successfully. DNCB is a synthetic compound
that works as a haptene in that it combines with proteins
to become a complete antigen resulting in an allergic contact
dermatitis in sensitized patients (Rosenberg and Drake,
1976).
The author has used DNCB to treat extensive alopecia
areata cases since 1978. In a group of these patients
treated about 25 years ago the percentages who had
either full regrowth of the hair in the treated areas or
enough had returned so that for all practical cosmetic
purposes it appeared to be full grown, the results were
as follows:
10–90% of scalp hair loss of o5 years duration: 90%
10–90% of scalp hair loss of 45 years duration: 60%
Alopecia totalis of o5 years duration: 70%
Alopecia totalis of 45 years duration: 40%
Alopecia universalis of o5 years duration: 50%
Alopecia universalis of 45 years duration: 25%
The average time to begin hair growth was 6 months, with
a range of 1–10 months. Side effects have been contact
dermatitis at the treatment sites (necessary for efficacy),
adenopathy, and autoeczematization in some cases of excess
local reaction. Rare patients develop urticaria. Although
DNCB fails the Ames Assay, a screening test in bacteria for
mutagenicity, it was not a carcinogen in animal testing.
(Weisberger et al., 1978)
Following is the protocol I have used for the DNCB
treatment:
Patients are sensitized by the application of 2000mg of
DNCB in 0.1ml acetone on approximately a 1-cm diameter
area on the shoulder, thigh, or bare scalp. A small bandaid is
applied, and this is covered by a waterproof dressing for
2 days. At least 2 weeks later, six strengths of DNCB in
aquaphor ranging from 0.1% through log dilutions to as weak
as 0.00000% are rubbed in small amounts to the arm, each
covered by a spot bandaid, and then a waterproof dressing is
placed over the area. Two days later, the patient returns for
observation of the tests. The weakest strength that may cause a
minimal reaction is prescribed for the patient to apply at home.
The goal of the application of the DNCB is to try to
constantly maintain a minimal reaction at all times. The
application can either be done without gloves followed by
careful hand washing or with the use of gloves or cotton
applicators. The areas are blotted after about 10min to take off
any excess so that inadvertent transfer of the medication to
other areas is minimized. The concentration used, the fre-
quency of application, and the duration it is present before
washing are the variables that are used to keep the reaction in
the most comfortable and convenient part of the effective
range. Antihistamines can be used to control pruritus. Treat-
ment is continued in each area until full density of hair returns
there or until 10 months of proper reaction have been
maintained without the growth of the hair. Any new or
recurrent patches are treated as they occur.
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